Xu S, Zheng Y, Ye M, Shen T, et al. Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response. BMC Cancer 2024;24:1064.
PMID: 39198775